AndreaBozzo/ceres-open-data-index huggingface dataset:
Household and family characteristics of persons including detailed information on stepfamilies, presence of grandparents in household, age group and gender: Canada, provinces and territories, census metropolitan areas and census agglomerations

Data on living arrangements of persons in private households including stepfamily status and presence of grandparents, age group and gender, Canada, provinces and territories, census metropolitan areas and census agglomerations, 2021 and 2016 censuses.

Organization: Statistics Canada | Statistique Canada
Census family status and household living arrangements, presence of parent in household, age group and gender: Canada, provinces and territories, census metropolitan areas and census agglomerations

Data on census family status and presence of parent in household, age group and gender for the population aged 20 to 34 in private households, Canada, provinces and territories, census metropolitan areas and census agglomerations, 2021, 2016 and 2011 censuses.

Organization: Statistics Canada | Statistique Canada
Positions of members of the Canadian Payments Association and Bank of Canada operations, Bank of Canada, monthly, inactive

This table contains 14 series, with data starting from 2007 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (1 items: Canada ...), Positions of members of the Canadian Payments Associations and buy back transactions with primary dealers (14 items: Positions of members of the Canadian Payments Association with the Bank of Canada; total overdraft loans; total amount; Positions of members of the Canadian Payments Association with the Bank of Canada; total positive balances; days transacted; Positions of members of the Canadian Payments Association with the Bank of Canada; total positive balances; total amount; Positions of members of the Canadian Payments Association with the Bank of Canada; total overdraft loans; days transacted ...).

Organization: Statistics Canada | Statistique Canada
Positions of members of the Canadian Payments Association and Bank of Canada operations, Bank of Canada, weekly, inactive

This table contains 14 series, with data starting from 2007 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (1 item: Canada); Positions of members of the Canadian Payments Associations and buy back transactions with primary dealers (14 items: Positions of members of the Canadian Payments Association with the Bank of Canada, total overdraft loans, total amount; Positions of members of the Canadian Payments Association with the Bank of Canada, total overdraft loans, days transacted; Positions of members of the Canadian Payments Association with the Bank of Canada, total positive balances, total amount; Positions of members of the Canadian Payments Association with the Bank of Canada, total positive balances, days transacted; ...).

Organization: Statistics Canada | Statistique Canada
Number of new cases and age-standardized rates of primary cancer, by stage at diagnosis, selected cancer type and sex

<p>Number of new cases and age-standardized rates of new cancer cases by stage at diagnosis from 2011 to the most recent diagnosis year available. Included are colorectal, lung, breast, cervical and prostate cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.<br>
</p>


Organization: Statistics Canada | Statistique Canada
Mother tongue by knowledge of official languages for children in couple families: Canada, provinces and territories and census metropolitan areas with parts

Data on mother tongue of married spouse or common-law partner by mother tongue of child, mother tongue of other married spouse or common-law partner, knowledge of official languages by married spouse or common law partner, knowledge of official language by child, knowledge of official languages by other married spouse or common-law partner and age of child for children under 18 years of age in couple families in private households.

Organization: Statistics Canada | Statistique Canada
Mother tongue by language spoken most often at home for children in different-gender couple families: Canada, provinces and territories and census metropolitan areas with parts

Data on mother tongue of woman married spouse or common-law partner by mother tongue of child, mother tongue of man married spouse or common-law partner, language spoken most often at home by child, other language spoken regularly at home by child and age of child for children under 18 years of age in different-gender couple families in private households.

Organization: Statistics Canada | Statistique Canada
Notice: Prescription Drug List (PDL): Human and Veterinary Antimicrobials

The purpose of this Notice of Amendment is to notify that Health Canada has amended 14 antimicrobial active ingredients or their salts or derivatives from non-prescription to prescription on the Veterinary Prescription Drug List (PDL). These amendments include adding antimicrobial classes, listing certain antimicrobials as derivatives rather than as antibiotic classes, and deleting qualifiers that are no longer necessary.

Organization: Health Canada | Santé Canada
Notice: Prescription Drug List (PDL): Hyoscine butylbromide

The purpose of this Notice of Amendment is to notify that Health Canada will switch injectable Hyoscine butylbromide to prescription status from ethical status for human use by adding it to the Human Prescription Drug List (PDL). Injectable Hyoscine butylbromide is already listed on the Veterinary Prescription Drug List. 

Organization: Health Canada | Santé Canada
Notice: Prescription Drug List (PDL): Vitamin D

The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of Vitamin D on the Prescription Drug List (PDL) to allow non-prescription status for products a) containing up to 62.5 µg or 2,500 International Units (IU)/dosage form for oral use; or b) with a maximum recommended daily oral intake of 2,500 IU. Only the Human part of the PDL was revised. 

Organization: Health Canada | Santé Canada
Notice: Prescription Drug List (PDL): Multiple Additions (2021-05-27)

The purpose of this Notice of Amendment is to notify about the additions of: 
- Strain Russian BCG-I to the "including" column of the |Bacillus Calmette-Guérin (BCG)" entry on the Prescription Drug List for human and veterinary use,
- Bedinvetmab to the PDL for veterinary use, and
- Binimetinib, Brillant Blue G, encorafenib, eptinezumab, mecasermin, onasemnogene abeparvovec, ponesimod, ranolazine, triheptanoin and zanubrutinib to the PDL for human and veterinary use.

Organization: Health Canada | Santé Canada
Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23)

The purpose of this Notice of Amendment is to notify about the additions of the following medicinal ingredients on the Prescription Drug List (PDL) for human and veterinary use: Brexucabtagene autoleucel; Idecabtagene vicleucel; Pitolisant; Risdiplam; Selpercatinib; Solriamfetol; Tepotinib; Tildrakizumab; Trastuzumab; deruxtecan.

Organization: Health Canada | Santé Canada
Notice: Prescription Drug List (PDL): Multiple Additions (2021-09-10)

The purpose of this Notice of Amendment is to notify about the additions of: Elexacaftor, Inclisiran, Ospemifene, Pralsetinib and Tafasitamab to the Prescription Drug List (PDL) for human and veterinary use, and Frunevetmab to the PDL for veterinary use.

Organization: Health Canada | Santé Canada
Notice: Prescription Drug List (PDL): Multiple Additions (2021-10-21)

The purpose of this Notice of Amendment is to notify of the addition of the following medicinal ingredients on the Prescription Drug List (PDL) for human and veterinary use: Infigratinib or its salts, Lurbinectedin or its salts or derivatives, Pemigatinib or its salts, Propylthiouracil or its salts, Sacituzumab govitecan, and Sotorasib. 

Organization: Health Canada | Santé Canada
Notice: Prescription Drug List (PDL): Multiple Additions (2020-02-13)

The purpose of this Notice of Amendment is to notify about the additions of gemtuzumab ozogamacin, gilteritinib, icosapent ethyl, tafamidis, trifarotine and upadacitinib to the Prescription Drug List (PDL) for human and/or veterinary use.

Organization: Health Canada | Santé Canada
Notice: Prescription Drug List (PDL): Multiple additions (2020-07-15)

The purpose of this Notice of Amendment is to notify about the additions of Alpelisib, Baloxavir marboxil, Betula verrucosa (white birch), Brolucizumab, Cabotegravir, Caplacizumab, Ciclesonide, Darolutamide, Entrectinib, Fremanezumab, Glasdegib, Isatuximab, Siponimod, Tenapanor, Tetracosactide and Tucatinib to the Prescription Drug List (PDL) for human and/or veterinary use.

Organization: Health Canada | Santé Canada
Guidance Document : Post-Notice of Compliance (NOC) Changes: Quality Document

This guidance document applies to sponsors intending to make changes to new drugs that have received a NOC pursuant to Section C.08.004 of the Food and Drug Regulations. In the absence of a guidance specific to Quality changes to drugs which were approved through a Drug Identification Application - Biologics (DIN-B drugs), this guidance document applies to those products. This guidance also applies to those submissions for which a NOC has been recommended but issuance of the NOC has been placed on hold.

Organization: Health Canada | Santé Canada
Guidance Document: Notice of Compliance with Conditions (NOC/c)

This guidance document combines and supercedes the policy and guidance documents for Notices of Compliance with Conditions (NOC/c) dated June 12, 2007. The revisions to this document incorporate the provision for the filing of Abbreviated New Drug Submissions (ANDSs) or Supplement to an Abbreviated New Drug Submissions (SANDSs) that reference a Canadian Reference Product (CRP) with NOC/c indications.

Organization: Health Canada | Santé Canada
Notice - Prescription Drug List (PDL): Lovastatin

The purpose of this Notice of Amendment is to announce the revised listing for lovastatin on the Prescription Drug List (PDL). As stated in the Notice of Intent to Amend, posted June 4, 2014, the revision will allow lovastatin to be marketed as a nonprescription product. Only the Human part of the PDL has been revised.

Organization: Health Canada | Santé Canada
Health Infobase

The award-winning Health Infobase, a sub-domain of Canada.ca, provides Canadian health information on a wide variety of topics including chronic and infectious diseases, injuries, mental health, health behaviours, health inequalities, consumer products, pesticides, wastewater, wildfires, and many more. 
In collaboration with subject matter experts, the Health Infobase team develops easy-to-use data visualizations including interactive and accessible data tools, allowing users to easily access, explore and understand Canadian health information.
By using both filters and free-text search options, users can view data products from different data sources in both static and interactive formats. Many data products have downloadable data sets, which are also available on the Open Data Portal.


Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
SOCI committee briefing binder: Appearance of Minister of Employment, Workforce Development and Disability Inclusion – March 22, 2023

Appearance by the Minister of Employment, Workforce Development and Disability Inclusion, Carla Qualtrough, before the Standing Senate Committee on Social Affairs, Science and Technology (SOCI) - March 22, 2023

Organization: Employment and Social Development Canada | Emploi et Développement social Canada
Costs of crime in Canada, 2014

Crime in Canada is a costly social phenomenon that affects everyone. The effects of crime are far-reaching and can include:
-direct financial costs to the institutions that make up the criminal justice system;
-ndirect costs to other social institutions and to the Canadian economy more broadly; and,
-physical, emotional, and financial toll costs to victims and their families.
While some of these costs are tangible and more easily counted (e.g., actual dollars spent by an institution), others are intangible and more difficult to measure (e.g., pain and suffering). An important body of work has however, attempted to translate the intangible impacts of crime into economic losses or costs.Footnote1 Interpreting the impacts of crime in this way can help policy makers to budget and allocate resources more effectively. It can also help to develop evidence-based strategies for crime-prevention that weigh the costs of crime against the costs of social interventions. Such strategies could include, for example, investing in social programs that prevent and reduce the effect of crime on people, businesses, institutions, and the Canadian economy

Organization: Department of Justice Canada | Ministère de la Justice Canada
HUMA committee briefing binder: Appearance of Minister of Families, Children and Social Development – March 10, 2023

Appearance by the Minister of Minister of Families, Children and Social Development, Karina Gould, before the Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with Disabilities (HUMA) – C-35 – March 10, 2023

Organization: Employment and Social Development Canada | Emploi et Développement social Canada
Briefing material – Appearance before the House of Commons Standing Committee on Procedure and House Affairs (March 2, 2023)

Briefing material to the attention of the Commissioner of Canada Elections for an appearance before the House of Commons Standing Committee on Procedure and House Affairs, which took place on March 2, 2023 in the context of the committee's study into foreign interference in federal elections.

Organization: Commissioner of Canada Elections  | Commissaire aux élections fédérales
Impact of obstacles experienced on the ability of the business or organization to purchase or sell goods or services across provincial and territorial borders over the last 12 months, third quarter of 2023

Impact of obstacles experienced on the ability of the business or organization to purchase or sell goods or services across provincial and territorial borders over the last 12 months, by North American Industry Classification System (NAICS), business employment size, type of business, business activity and majority ownership, third quarter of 2023.<br>

Organization: Statistics Canada | Statistique Canada
Extent to which a reduction or elimination of various obstacles would affect the business's or organization's willingness to purchase or sell goods or services across provincial and territorial borders, third quarter of 2023

Extent to which a reduction or elimination of various obstacles would affect the business's or organization's willingness to purchase or sell goods or services across provincial and territorial borders, by North American Industry Classification System (NAICS), business employment size, type of business, business activity and majority ownership, third quarter of 2023.<br>

Organization: Statistics Canada | Statistique Canada
Business or organization plans to expand, restructure, acquire, invest, transfer, sell or close over the next 12 months, third quarter of 2023

Business or organization plans to expand, restructure, acquire, invest, transfer, sell or close over the next 12 months, by North American Industry Classification System (NAICS), business employment size, type of business, business activity and majority ownership, third quarter of 2023.<br>

Organization: Statistics Canada | Statistique Canada
Reasons the business or organization did not purchase or sell goods or services across provincial and territorial borders over the last 12 months, third quarter of 2023

Reasons the business or organization did not purchase or sell goods or services across provincial and territorial borders over the last 12 months, by North American Industry Classification System (NAICS), business employment size, type of business, business activity and majority ownership, third quarter of 2023.<br>

Organization: Statistics Canada | Statistique Canada
Forms of misinformation or disinformation business or organization has been a victim of over the last 12 months, third quarter of 2023

Forms of misinformation or disinformation business or organization has been a victim of over the last 12 months, by North American Industry Classification System (NAICS), business employment size, type of business, business activity and majority ownership, third quarter of 2023.<br>

Organization: Statistics Canada | Statistique Canada
Guidance on Cloud Security Assessment and Authorization (ITSP.50.105)

"Cloud computing has the potential to provide your organization with flexible, on-demand, scalable and self-service IT services. To benefit from cloud computing, your organization must ensure that security risks are properly managed, cloud specific security considerations are addressed, and security controls of cloud-based services are properly assessed before authorized.

You organization can use the guidance in this document to assist with its security assessment and authorization of cloud-based services. "


Organization: Communications Security Establishment Canada | Centre de la sécurité des télécommunications Canada
Parasites of slimy sculpin (Cottus cognatus) as indicators of water quality in the tributaries of the Athabasca River

This project examined the use of parasites of slimy sculpin (Cottus cognatus) as indicators of water quality in the Athabasca River. Specimens of C. cognatus were sampled from four tributaries to assess patterns of helminth parasite community structure in this fish and to study the composition and diversity of its parasite communities in relation to water quality.

All data are a part subject of a publication containing method details, full QA/QC, interpretation and conclusions: Braicovich, P. E., McMaster, M., Glozier, N. E., & Marcogliese, D. J. (2020). Distribution of parasites of slimy sculpin Cottus cognatus Richardson, 1836 (Scorpaeniformes: Cottidae) in the Athabasca drainage, Alberta, Canada, and their relation to water quality. Parasitology research, 119(10), 3243–3254. doi.org/10.1007/s00436-020-06819-9

Supplemental Information

Supporting projects: Oil Sands Monitoring (OSM)

Organization: Environment and Climate Change Canada | Environnement et Changement climatique Canada
Lanthanides Release and Partitioning in Municipal Wastewater Effluents

This study investigated the fate of rare earth elements (lanthanides) in in wastewater after being treated by various processes conducted at six different wastewater treatment plants throughout Canada. This research also focused specifically on the fate of medical gadolinium (Gd) which is used primarily in medical imaging activities.  Samples were collected from each site over a three-day sampling regime in the summer of 2018. Surface water was collected for comparison from the Athabasca River in Alberta, Canada and from the St. Lawrence River in Quebec, Canada.


All data are a part subject of a publication containing method details, full QA/QC, interpretation and conclusions. Citation: Turcotte, P.; Smyth, S.A.; Gagné, F.; Gagnon, C. Lanthanides Release and Partitioning in Municipal Wastewater Effluents. Toxics 2022, 10, 254. doi.org/10.3390/toxics10050254


Supplemental Information


The Chemicals Management Plan (CMP) is a Government of Canada initiative aimed at reducing the risks posed by chemicals to Canadians and their environment. A key element of the Chemicals Management Plan is the monitoring and surveillance of levels of harmful chemicals in Canadians and their environment. Monitoring and surveillance are essential to identify and track exposure to hazards in the environment and associated health implications. Monitoring and surveillance programs provide the basis for making sound and effective public health and environmental health policies and interventions, as well as measuring the efficacy of control measures. 


In support of the Chemicals Management Plan, monitoring and surveillance initiatives were established to support Health Canada and Environment and Climate Change Canada scientists, in collaboration with external partners and researchers, to advance our knowledge. This initiative has allowed the Government of Canada to increase its commitment to a number of existing monitoring initiatives, as well as to support new efforts. 


For more information on the Chemicals Management Plan, please visit https://www.canada.ca/en/health-canada/services/chemical-substances/chemicals-management-plan.html

Organization: Environment and Climate Change Canada | Environnement et Changement climatique Canada
The comet assay, a sensitive biomarker of water quality improvement following adoption of beneficial agricultural practices?

Numerous actions have been undertaken by farmers to attenuate the impact of agricultural activities on aquatic ecosystems. The identification of biomarkers that respond quickly to water quality improvement could facilitate the assessment of adopted alternative practices and help maintain mobilization among stakeholders. Here, we evaluated the potential of the Comet assay, a biomarker of genotoxic effects, using a freshwater mussel, Elliptio complanata, as a model animal. The frequency of DNA damage was assessed in hemocytes of mussels collected from a pristine habitat (MSH) and caged for 8 weeks in the Pot au Beurre River (PAB), a tributary of Lake St-Pierre (QC, Canada) impacted by agricultural activities. Pesticides and water quality parameters were also measured in surface water on a weekly basis during the caging period. Our findings suggest that the Comet assay is a sensitive tool for the early detection of changes in water toxicity following the adoption of agricultural beneficial practices.


All data are a part subject of a publication containing method details, full QA/QC, interpretation and conclusions. Citation: Gendron, A.D., Lacaze, É., Taranu, Z.E., Gouge, R., Larbi-Youcef, Y., Houde, M., André, C., Gagné, F., Triffault-Bouchet, G. and Giroux, I. (2023), The Comet Assay, a Sensitive Biomarker of Water Quality Improvement Following Adoption of Beneficial Agricultural Practices?. Environ Toxicol Chem. doi.org/10.1002/etc.5711


Supplemental Information


The St. Lawrence Action Plan (SLAP) 2011 to 2026 (see http://planstlaurent.qc.ca/en/home.html) is the latest Canada-Quebec Agreement on the St. Lawrence and builds on the four previous agreements implemented since 1988.


The agreement aims to conserve and enhance the St. Lawrence. It is based on strong collaboration and the pooling of resources and expertise between the governments of Canada and Quebec. As part of their respective responsibilities for the management of the St. Lawrence basin, these two governments recognize the need for close cooperation to tackle the environmental challenges facing this important ecosystem. Other partners are also joining in this initiative, including local organizations, environmental groups, research centres, and universities.


For more information on SLAP, please visit https://www.canada.ca/en/environment-climate-change/services/environmental-funding/ecosystem-initiatives/st-lawrence-action-plan.html

Organization: Environment and Climate Change Canada | Environnement et Changement climatique Canada